Giovanna D'Arcangelo

Prof. Giovanna D'Arcangelo

Dipartimento di Medicina dei Sistemi, University of Rome Tor Vergata | UNIROMA2, Rome, Italy
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2002 in Progress in Neurobiology
Verified
Journal Article
Closed access
MAMassimo Avoli
Massimo Avoli
MDMargherita D’antuono
Margherita D’antuono
JLJacques Louvel
Jacques Louvel
RKRüdiger Köhling
Rüdiger Köhling
Giuseppe BiaginiGiuseppe Biagini
Giuseppe Biagini
VTVirginia Tancredi
Virginia Tancredi

1 November 1992 in Neuroscience Letters
Verified
Journal Article
Closed access
VTVirginia Tancredi
Virginia Tancredi
GDGiovanna D'Arcangelo
Giovanna D'Arcangelo
Francesca GrassiFrancesca Grassi
Francesca Grassi
PTPaolo Tarroni
Paolo Tarroni
GPGabriella Palmieri
Gabriella Palmieri
FEFabrizio Eusebi
Fabrizio Eusebi

1 August 2000 in Journal of Neurochemistry
Verified
Journal Article
Open access
PDF file
VTVirginia Tancredi
Virginia Tancredi
MDMargherita D'Antuono
Margherita D'Antuono
CCCarla Cafè
Carla Cafè
SGSilvia Giovedì
Silvia Giovedì
MBMaria Cristina Buè
Maria Cristina Buè
FBFabio Benfenati
Fabio Benfenati
Several cytokines have short‐term effects on synaptic transmission and plasticity that are thought to be mediated by the activation of intracellular protein kinases. We have studied the effects of interleukin‐6 (IL‐6) on the expression of paired pulse facilitation (PPF), posttetanic potentiation (PTP), and long‐term potentiation (LTP) in the CA1 region of the hippocampus as well as on the activation of the signal transducer and activator of transcription‐3 (STAT3), the mitogen‐activated protein kinase ERK (MAPK/ERK), and the stress‐activated protein kinase/c‐Jun NH2‐terminal kinase (SAPK/JNK). IL‐6 induced a marked and dose‐dependent decrease in the expression of PTP and LTP that could be counteracted by the simultaneous treatment with the tyrosine kinase inhibitor lavendustin A (LavA) but did not significantly affect PPF. The IL‐6‐induced inhibition of PTP and LTP was accompanied by a simulation of STAT3 tyrosine phosphorylation and an inhibition of MAPK/ERK dual phosphorylation, in the absence of changes in the state of activation of SAPK/JNK. Both effects of IL‐6 on STAT3 and MAPK/ERK activation were effectively counteracted by LavA treatment. The results indicate the tyrosine kinases and MAPK/ERK are involved in hippocampal synaptic plasticity and may represent preferential intracellular targets for the actions of IL‐6 in the adult nervous system.

1 August 2008 in Experimental Neurology
Verified
Journal Article
Closed access
CFC. Frank
C. Frank
SRStefano Rufini
Stefano Rufini
VTVirginia Tancredi
Virginia Tancredi
RFR. Forcina
R. Forcina
DGD. Grossi
D. Grossi
GDGiovanna D'Arcangelo
Giovanna D'Arcangelo

1 April 2000 in European Journal of Neuroscience
Verified
Journal Article
Closed access
PDF file
GDGiovanna D'Arcangelo
Giovanna D'Arcangelo
VTVirginia Tancredi
Virginia Tancredi
FOFranco Onofri
Franco Onofri
MDMargherita D'Antuono
Margherita D'Antuono
SGSilvia Giovedì
Silvia Giovedì
FBFabio Benfenati
Fabio Benfenati

Verified
Journal Article
Open access
PDF file
RBRoberto Bonanni
Roberto Bonanni
ICIda Cariati
Ida Cariati
Umberto TarantinoUmberto Tarantino
Umberto Tarantino
GDGiovanna D'Arcangelo
Giovanna D'Arcangelo
VTVirginia Tancredi
Virginia Tancredi
Scientific evidence has demonstrated the power of physical exercise in the prevention and treatment of numerous chronic and/or age-related diseases, such as musculoskeletal, metabolic, and cardiovascular disorders. In addition, regular exercise is known to play a key role in the context of neurodegenerative diseases, as it helps to reduce the risk of their onset and counteracts their progression. However, the underlying molecular mechanisms have not yet been fully elucidated. In this regard, neurotrophins, such as brain-derived neurotrophic factor (BDNF), nerve growth factor (NGF), glia cell line-derived neurotrophic factor (GDNF), neurotrophin-3 (NT-3), and neurotrophin-4 (NT-4), have been suggested as key mediators of brain health benefits, as they are involved in neurogenesis, neuronal survival, and synaptic plasticity. The production of these neurotrophic factors, known to be increased by physical exercise, is downregulated in neurodegenerative disorders, suggesting their fundamental importance in maintaining brain health. However, the mechanism by which physical exercise promotes the production of neurotrophins remains to be understood, posing limits on their use for the development of potential therapeutic strategies for the treatment of neurodegenerative diseases. In this literature review, we analyzed the most recent evidence regarding the relationship between physical exercise, neurotrophins, and brain health, providing an overview of their involvement in the onset and progression of neurodegeneration.